Scientific Journals
Diagnostic Accuracy of Single-Lead Electrocardiograms Using the Kardia Mobile App and the Apple Watch 4: Validation Study.
Klier K, Koch L, Graf L, Schinköthe T, Schmidt A.
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions.
Debes AM, Koenig A, Strobach D, Schinkoethe T, Forster M, Harbeck N, Wuerstlein R.
Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy.
Harbeck N, Kates R, Schinköthe T, Schumacher J, Wuerstlein R, Degenhardt T, Lüftner D, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Fasching PA, Schmidt M; AGO-B, WSG PreCycle investigators.
Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development Study.
Klier K, Patel YJ, Schinköthe T, Harbeck N, Schmidt A.
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers.
Schindler F, Schinkoethe T, Mahner S, Kolben T, Wuerstlein R, Culmsee C, Harbeck N, Eggersmann TK.
Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient's satisfaction with therapy: The CINDERELLA trial.
Kaidar-Person O, Antunes M, Cardoso JS, Ciani O, Cruz H, Di Micco R,
Gentilini OD, Gonçalves T, Gouveia P, Heil J, Kabata P, Lopes D, Martinho M, Martins H, Mavioso C, Mika M, Montenegro H, Oliveira HP, Pfob A, Rotmensz N, Schinköthe T, Silva G, Tarricone R, Cardoso MJ; CINDERELLA Consortium.
Significantly longer time to deterioration of quality of life due to CaNKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.
Harbeck N, Fasching PA, Wuerstlein R, Degenhardt T, Lüftner D, Kates RE, Schumacher J, Räth P, Hoffmann O, Lorenz R, Decker T, Reinisch M, Göhler T, Staib P, Gluz O, Schinköthe T, Schmidt M; AGO-B WSG PreCycle investigators.
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant.
Degenhardt T, Fasching PA, Lüftner D, Müller V, Thomssen C, Schem C, Witzel I, Decker T, Tesch H, Kümmel S, Uleer C, Wuerstlein R, Hoffmann O, Warm M, Marschner N, Schinköthe T, Kates RE, Schumacher J, Otremba B, Zaiss M, Harbeck N, Schmidt M; PreCycle Investigators.
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor- Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical Trial.
Gluz O, Nitz UA, Christgen M, Kuemmel S, Holtschmidt J, Schumacher J, Hartkopf A, Potenberg J, Lüedtke-Heckenkamp K, Just M, Schem C, von Schumann R, Kolberg-Liedtke C, Eulenburg CZ, Schinköthe T, Graeser M, Wuerstlein R, Kates RE, Kreipe HH, Harbeck N.
Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial
L. Michel, P. Romar, M. Feisst, D. Hamberger, D. Schwarz, E. Kurre, E. Klein, M.O. Breckwoldt, A. Priester, M. Weiler, K. Smetanay, C. Fremd, D. Jäger, M. Bendszus, F. Marmé, A. Schneeweiss
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
Fey T, Erickson N, Stahler A, Muenchhoff M, Keppler OT, Ruehlmann K, Krauss-Pfeiffer G, Steinberg H, Graf A, Krebs S, Blum H, Khatamzas E, Seynstahl S, Casuscelli J, Markwardt D, Forstpointner R, Schinköthe T, von Bergwelt-Baildon M, Heinemann V.
Patient-reported outcome measures obtained via E-Health tools ease the assessment burden and encourage patient participation in cancer care (PaCC Study).
Erickson N, Schinkoethe T, Eckhardt C, Storck L, Joos A, Liu L, Ballmer PE, Mumm F, Fey T, Heinemann V.
A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application Development.
Schinköthe T, Gabri MR, Mitterer M, Gouveia P, Heinemann V, Harbeck N,
Subklewe M.
Individualized eHealth Support for Oncological Therapy Management.
Schinköthe T.
Books
Innovationsfonds – Transfer in die Regelversorgung
Engelhausen, R., & Scholz, S. (2020)
Medhochzwei Verlag GmbH
ISBN 978-3-86216-737-1
ISBN 978-3-86216-737-1
Die Digitale Transformation der Pflege
Elmer, A., & Matusiewicz, D. (2019)
Medizinisch Wissenschaftliche Verlagsgesellschaft mbH & Co. KG.
ISBN 978-3-95466-404-7
ISBN 978-3-95466-404-7
Information
Get In Touch
CANKADO GmbH
Kyivstraße 9
81735 Munich
Germany
Kyivstraße 9
81735 Munich
Germany
© 2024 CANKADO. All rights reserved.
Information
Contact
To contact call
Toll free number for Germany
You can also drop your message via contact page
Training
Check our Online Academy for further details
